Vali Aliyev

6PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 15, 2026
An integrated host vulnerability score is associated with survival in advanced NSCLC treated with nivolumab: a PET/CT-based real-world study.

|May 06, 2026
Immune-Mediated upper gastrointestinal toxicities reported With immune checkpoint inhibitors: An analysis of the food and drug administration adverse event reporting system (FAERS).

|Mar 28, 2026
Prognostic Impact of Early Metabolic Response on Interim 18F-FDG PET/CT in HR+/HER2- Metastatic Breast Cancer Treated with CDK4/6 Inhibitors.

Vali Aliyev, Ali Kaan Güren, Murad Guliyev

|Dec 30, 2025
Stage II colon cancer: does ChatGPT recommend more intensive adjuvant therapy? A comparison with MDT decisions.

Zeliha Birsin, Seda Jeral, Selin Cebeci

|Sep 27, 2025
Low Skeletal Muscle Index as a Predictor of Pathological Complete Response in HER-2 Positive and Triple-Negative Breast Cancer.

Murat Günaltılı, Murad Guliyev, Mehmet Cem Fidan

|Sep 27, 2025
Comparative Efficacy and Cost-Effectiveness of Denosumab Versus Zoledronic Acid in Cancer Patients with Bone Metastases.

Vali Aliyev, Murad Guliyev, Murat Günaltılı

Pageof 1

Frequent Collaborators

5 joint publications

Özkan Alan

4 joint publications

Murat Günaltılı

4 joint publications

Hamza Abbasov

3 joint publications

Seda Jeral